Beta‐blockers for hypertension
140 results
1 - 100
Beta‐blockers for hypertension- Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension
Beta-blockers for mild to moderate hypertension in pregnancy - Oral beta‐blockers for mild to moderate hypertension during pregnancy
- Beta-blockers as second-line therapy for primary hypertension
- Dual alpha and beta blockers for primary hypertension
- Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension
- Blood pressure lowering efficacy of beta‐blockers as second‐line therapy for primary hypertension
- Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension: Cochrane systematic review
- Drug treatment for hypertension
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Beta-adrenergic blocking agents and intermittent claudication
- Beta-blockers against other antihypertensive drugs
- Cardioselective beta‐blockers for reversible airway disease
- Reversal of left ventricular hypertrophy in essential hypertension
- Beta-blockers for preventing stroke recurrence: Cochrane systematic review
- First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection: Cochrane systematic review
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Beta blockers for peripheral arterial disease: Cochrane systematic review
- Beta‐blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension: Cochrane systematic review
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- Band ligation versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Time course for blood pressure lowering of beta‐blockers with partial agonist activity
- Chronic diseases and pregnancy
- First-line renin angiotensin system inhibitors versus other drug classes for hypertension
- Choice of antihypertensive drug in the diabetic patient from prognostic point of view
Beta-blockers and tricyclic antidepressants are more commonly associated with orthostatic hypotension- Calcium channel blockers versus other classes of drugs for hypertension
- Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- First‐line drugs for hypertension
- Adverse effects of hypertension treatment during pregnancy
- Use of medication during pregnancy
- Secondary hypertension
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Follow-up of type 1 diabetes
- Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion‐dependent beta thalassaemia
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Pharmacotherapy for hypertension in the elderly
- Calcium channel blockers versus other classes of drugs for hypertension
- Different antihypertensive agents as first line therapies
- Pharmacological interventions for hypertension in children
- Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices
- Metabolic syndrome
- Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices
- Treatment of hypertension in peripheral arterial disease
- Antihypertensive drugs and incident diabetes
- Chronic heart failure
- Beta-blockers associated with improved morbidity/mortality in COPD patients
- Erectile dysfunction
- Chronic coronary syndrome (coronary heart disease)
- Lowering blood pressure does not decrease the risk of T2DM in persons with hypertension; ACEIs/ARBs do
- Hypertension in elderly patients
- Prevention of atrial fibrillation
- Exercise stress test